Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Moderate severity 		Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
Moderate severity 		Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Moderate severity 		Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
Sotrovimab
Moderate severity 		Emergency use authorization Experimental Antiviral Jul/14/2022
Bamlanivimab
Moderate severity 		Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Moderate severity 		Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Convalescent plasma
Moderate severity 		Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Moderate severity 		Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Moderate severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Moderate severity 		Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Colchicine
Moderate severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Dexamethasone
Moderate severity 		Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
ChAdOx1 nCoV-19
Moderate severity 		Emergency use authorization Experimental Vaccine Jan/04/2022
Tocilizumab
Moderate severity 		Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Moderate severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
Moderate severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Ritonavir
Moderate severity 		Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Favipiravir
Moderate severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Chloroquine phosphate
Moderate severity 		Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Hydroxychloroquine sulfate
Moderate severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Export (.csv)